Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Kendi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Nuclear Medicine|August 15, 2017
PET/CT in an 8-Year-Old Girl With Epstein-Barr Virus-Associated Smooth Muscle TumorIshan Garg, Maria J Baladron Zanetti, Saba Yasir, et al.
Clinical Nuclear Medicine|October 9, 2015
Standardized Added Metabolic Activity Predicts Survival After Intra-arterial Resin-Based 90Y Radioembolization Therapy in Unresectable Chemorefractory Metastatic Colorectal Cancer to the LiverFaramarz Edalat, Juan C Camacho, Nima Kokabi, et al.
Cancer Treatment Reviews|March 18, 2023
Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancerJeremie Calais, Stephen M Eulau, Linda Gardner, et al.
Nuclear Medicine Communications|May 9, 2023
Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesionsShannon Fortin Ensign, Muskan Agarwal, Molly Klanderman, et al.
EJNMMI Research|March 15, 2026
Cell surface oncofetal antigens in prostate cancer: therapeutic potential and radioligand targetingEmirhan Harbi, Gokce Belge Bilgin, Louise Emmett, et al.
Journal of Cardiac Failure|July 28, 2021
Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center ExperienceMohamed Elwazir, Megan L Krause, John P Bois, et al.
The Prostate|October 11, 2021
Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapyMasaya Jimbo, Jack R Andrews, Mohamed E Ahmed, et al.
The Prostate|September 12, 2022
Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysisJamal Alamiri, Cameron J Britton, Mohamed E Ahmed, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
A VISION Substudy of Reader Agreement on <sup>68</sup>Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for <sup>177</sup>Lu-PSMA-617 Radioligand TherapyPhillip H Kuo, Don C Yoo, Ryan Avery, et al.
The Prostate|June 2, 2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastasesAlex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Nuclear Medicine|August 15, 2017
PET/CT in an 8-Year-Old Girl With Epstein-Barr Virus-Associated Smooth Muscle TumorIshan Garg, Maria J Baladron Zanetti, Saba Yasir, et al.
Clinical Nuclear Medicine|October 9, 2015
Standardized Added Metabolic Activity Predicts Survival After Intra-arterial Resin-Based 90Y Radioembolization Therapy in Unresectable Chemorefractory Metastatic Colorectal Cancer to the LiverFaramarz Edalat, Juan C Camacho, Nima Kokabi, et al.
Cancer Treatment Reviews|March 18, 2023
Incorporating radioligand therapy in clinical practice in the United States for patients with prostate cancerJeremie Calais, Stephen M Eulau, Linda Gardner, et al.
Nuclear Medicine Communications|May 9, 2023
Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesionsShannon Fortin Ensign, Muskan Agarwal, Molly Klanderman, et al.
EJNMMI Research|March 15, 2026
Cell surface oncofetal antigens in prostate cancer: therapeutic potential and radioligand targetingEmirhan Harbi, Gokce Belge Bilgin, Louise Emmett, et al.
Journal of Cardiac Failure|July 28, 2021
Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center ExperienceMohamed Elwazir, Megan L Krause, John P Bois, et al.
The Prostate|October 11, 2021
Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapyMasaya Jimbo, Jack R Andrews, Mohamed E Ahmed, et al.
The Prostate|September 12, 2022
Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysisJamal Alamiri, Cameron J Britton, Mohamed E Ahmed, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
A VISION Substudy of Reader Agreement on <sup>68</sup>Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for <sup>177</sup>Lu-PSMA-617 Radioligand TherapyPhillip H Kuo, Don C Yoo, Ryan Avery, et al.
The Prostate|June 2, 2022
The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastasesAlex J Liu, Heidi E Kosiorek, Benjamin E Ueberroth, et al.
Pageof 3